Enable Biosciences Joins the JDRF One Walk to Raise Funds and Awareness for Type 1 Diabetes
Enable Biosciences Joins the JDRF One Walk to Raise Funds and Awareness for Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin production by attacking pancreatic islet cells, leading to chronic and challenging-to-manage disease. With 40,000 new cases annually, T1D affects more than 1.25 million Americans. Autoantibody markers appear well in advance of symptoms, and pilot studies have shown that screening for these markers can reduce the rates of often-deadly diabetic ketoacidosis at diagnosis, reduce medical complications and potentially improve patients’ quality of life.
JDRF is the world’s largest non-profit funder of T1D research that focuses on supporting individuals and families impacted by T1D. Any proceeds raised will be used to fund research with the goal of finding a cure and the best forms of disease detection moving forward.
Enable Bioscience’s ADAP assay for T1D has been ranked amongst the top-performing assays in the world as presented by the Immunology of Diabetes Society (IDS) Congress in 2018 for the early detection of antibodies. Enable Biosciences has also partnered with Hamilton Robotics to bring the improved assay to the Enable ADAP STAR platform, allowing for high-throughput population screening. Enable Biosciences provides laboratory services in partnership with JDRF’s T1Detect, a nationwide program that provides type 1 diabetes risk testing services (https://www.jdrf.org/t1d-resources/t1detect/).
We hope you will consider donating to our fundraising goal of $1,000! The final donation amount will be matched by Enable Biosciences up to $1,000. By donating to the JDRF One Walk, you'll be part of the lasting footprint we'll make for the T1D community now and for generations to come.
Thank you for your support!
The Enable Biosciences Team